Finance

Lists
BBNX:NASDAQ
Beta Bionics Inc
17,86 $
+1,30%
(+0,23) 1D
17,86 $
0,00% (0,00)
After hours
Closed: 12 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBNX...
Open
17,94 $
High
18,56 $
Low
17,71 $
Mkt. cap
940,04 млн
Avg. vol.
1,34 млн
Volume
0,00
52-wk high
32,71 $
52-wk low
8,80 $
EPS
-1,65 $
Shares outstanding
52,64 млн
No. of employees
422
Open
17,94 $
High
18,56 $
Low
17,71 $
Mkt. cap
940,04 млн
Avg. vol.
1,34 млн
Volume
0,00
52-wk high
32,71 $
52-wk low
8,80 $
EPS
-1,65 $
Shares outstanding
52,64 млн
No. of employees
422
News stories
From web sources and news partners
About Beta Bionics Inc
CEO-
Employees422
Founded2015
HeadquartersИрвайн, Калифорния, Америка Құрама Штаттары
SectorMedical device
Websitebetabionics.com
Analyst ratings
Based on 15 analysts giving stock ratings to BBNX in the past 3 months
Buy
Buy
11
Hold
4
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for BBNX in the last 3 months.
Highest
Current 17,86 $
30,40 $ (+70,21%)
Average
24,17 $ (+35,33%)
Lowest
16,00 $ (-10,41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Toomey
Jefferies
Buy
Initiated
30,00 $
+68%
10/12/2026
Christopher Pasquale
Barclays
Buy
Initiated
30,00 $
+68%
10/06/2026
Unknown Analyst
Barclays
Buy
Initiated
30,00 $
+68%
10/06/2026
Richard Newitter
Truist Financial
Buy
Reiterated
28,00 $
+56,8%
09/24/2026
Larry Biegelsen
Wells Fargo
Buy
Initiated
28,00 $
+56,8%
09/23/2026
Frank Takkinen
Lake Street
Buy
Reiterated
25,00 $
+40%
09/22/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
27,00 $
+51,2%
09/17/2026
Jonathan Block
Stifel Nicolaus
Buy
Maintained
22,00 $
+23,2%
09/15/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
16,00 $
-10,4%
09/15/2026
Patrick Wood
UBS
Buy
Maintained
25,00 $
+40%
09/15/2026
Travis Steed
Bank of America Securities
Hold
Reiterated
20,00 $
+12%
09/14/2026
Mathew Blackman
TD Cowen
Hold
Maintained
18,00 $
+0,8%
09/14/2026
Steven Lichtman
William Blair
Hold
Maintained
-
-
09/14/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
30,40 $
+70,2%
07/30/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
20,00 $
+12%
07/30/2026
Danielle Antalffy
UBS
Buy
Initiated
22,00 $
+23,2%
07/28/2026
David Roman
Goldman Sachs
Buy
Reiterated
19,00 $
+6,4%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
27,25 млн
32,12 млн
27,63 млн
32,01 млн
Cost of goods sold
12,13 млн
13,18 млн
11,19 млн
13,11 млн
Cost of revenue
12,13 млн
13,18 млн
11,19 млн
13,11 млн
Research and development expenses
8,20 млн
10,13 млн
10,36 млн
10,24 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23,97 млн
24,94 млн
30,35 млн
34,24 млн
Operating expense
32,16 млн
35,07 млн
40,71 млн
44,48 млн
Total operating expenses
44,30 млн
48,24 млн
51,90 млн
57,59 млн
Operating income
-17,04 млн
-16,12 млн
-24,27 млн
-25,58 млн
Other non operating income
1,00 мың
-
-
-2,00 мың
EBT including unusual items
-14,21 млн
-13,47 млн
-21,90 млн
-23,40 млн
EBT excluding unusual items
-14,21 млн
-13,47 млн
-21,90 млн
-23,40 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,21 млн
-13,47 млн
-21,90 млн
-23,40 млн
Net profit margin
-52,14%
-41,92%
-79,25%
-73,10%
Earnings per share
-0,33
-0,19
-0,36
-0,36
Interest and investment income
2,83 млн
2,66 млн
2,38 млн
2,18 млн
Interest expense
-
-
-
-
Net interest expenses
2,83 млн
2,66 млн
2,38 млн
2,18 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-16,66 млн
-15,59 млн
-23,69 млн
-24,87 млн
Gain or loss from assets sale
-
31,00 мың
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары